Drugs / Alginate-based reflux suppressant
Alginate-based reflux suppressant
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 4 | NCT02470117 Comparator | Jun 2015 → Jul 2016 | — | Chulalongkorn University | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Alginate-based reflux suppressant | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02470117 ↗ |
| Modality | Other / unclassified | “as medical devices, such as alginate raft forming antireflux agents” PMID 24096290 ↗ Oct 2013 |
| Route | Oral | “Alginate-based reflux suppressant 15 ml oral every 6 hours for 2 weeks” NCT02470117 ↗ |